Key facts
- Meltwind Advisory is an investor with 41 tracked portfolio companies.
- Notable positions include bit.bio, Healx, Nuclera, Chemify, Axol Bioscience.
Free account
See the whole book
- ·The book's top 25 — of 41 recorded positions
- ·Watchlist + alerts for Meltwind Advisory's activity
Create free account
No card required
Portfolio, priced
41 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| bit.bio | Biotechnology | $546.3M | — | |
| Healx | — | $275.9M | — | |
| Nuclera | — | $154.5M | — | |
| Chemify | — | $145.1M | — | |
| Axol Bioscience | — | $128.1M | — | |
| Relation | — | $124.7M | — | |
| LabGenius Therapeutics | — | $85.9M | — | |
| SolasCure | — | $57.0M | — | |
| Invizius | — | $47.8M | — | |
| Quibim | — | $46.1M | — | |
| Pangaea (Enterprise Systems) | — | $37.4M | — | |
| Shift Bioscience | — | $30.5M | — | |
| Sanius Health | — | $30.0M | — | |
| Infinitopes | — | $28.4M | — | |
| Enhanced Genomics | — | $28.1M | — | |
| + 26 more companies · a free account shows the top of the book | ||||
Frequently asked
- What companies does Meltwind Advisory invest in?
- Meltwind Advisory has 41 recorded portfolio companies, including bit.bio, Healx, Nuclera, Chemify.